biotech / news / / Fortune
The analysis includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters.
The White House estimates $733 billion could be saved over a decade from Trump's drug pricing policy.
KEY POINTS
- Few details of Trump's agreements with 17 pharmaceutical companies have been made public for independent review.
- The policy projects $64.3 billion in Medicaid savings over ten years due to lower drug prices.
- Pharmaceutical companies' profits rose 66% after joining the Trump prescription drug plan, per Sanders' staff.
COMPANIES
Summarized by Newsio from Fortune. How we summarize →